Relationship of morphological changes of blood cells with endothelial function, renal function and lipidemic profile in patients with type 2 diabetes mellitus with suboptimal glycemic control and hypertension.

Authors

  • N. O. Pertseva State institution “Dnipropetrovsk medical academy of the Ministry of Health of Ukraine”, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2016.1.62-71

Keywords:

diabetes mellitus type 2, hypertension, endothelial dysfunction, platelet hemostasis, relationship.

Abstract

Background. Many questions about the relationship between endothelial dysfunction and morphological substrate of hemostasis damage that occur during the progress of type 2 diabetes mellitus and arterial hypertension require clarification and further advance. Objective. The aim of this study is to determine the relationships between endothelial dysfunction, the degree of renal function damage, lipidemic profile and morphological changes of vascular-platelet hemostasis in patients with type 2 diabetes mellitus with suboptimal glycemic control and hypertension. Methods. In 87 patients with insufficient glycemic compensation using clinical, laboratory, morphological methods and correlational analysis were identified association between endothelial dysfunction, degree of renal function damage, lipidemic profile and morphological changes of vascular-platelet hemostasis. Results. Against the background of insufficient glycemic compensation glycated hemoglobin concentration tightly correlated with the share of activated platelets (r=+0.77; p<0.05), with the level of aggregated forms (r=+0.82; p<0.05) and the concentration of small blood platelet aggregates (r=+0.76; p<0.05), established a positive relationship with the share degranulated platelets (r=+0.60; p<0.05). Signs of atherogenic dyslipidemia triad that this contingent of patients indicated significant deviation from that of the control group not only had a correlation with the share of activated platelets and content of alpha and delta granules, but also formed a new moderate strength correlations with other observable parameters of platelet morphology. In particular, amid insufficient glycemic compensation formed reliable values of the coefficients of linear correlation in pairs: total cholesterol and activated platelets (r=-0.54), low density lipoprotein cholesterol and activated platelets (r=-0.51), low density lipoprotein cholesterol and aggregated forms (r=+0.59), low density lipoprotein cholesterol and degranulated platelets (r=+0.48). Also triglycerides level in these patients established statistically significant correlation with all studied parameters of intravascular platelet activation. Conclusion. It has been established that in the insufficient glycemic control by a significant strengthening relationships between indicators of endothelial dysfunction and damaged platelet hemostasis formed significant correlations of ultrastructural characteristics of platelets with clinical and laboratory signs of nephropathy and dyslipidemic changes.

References

  1. Dedov II, Shestakova MV, editors. [Diabe-tes: acute and chronic complications]. Moscow: Publishing house "Medical Information Agency"; 2011. 480 p. Russian.
  2. Epstein M. Diabetes and hypertension: the bad companions. Hypertension. 1997;15(2):55-62.
  3. Torimoto K, Okada Y, Mori H, Tanaka Y. Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol. 2013;13:18-24.
  4. Xu J, Zou MN. Molecular insights and thera-peutic targets for diabetic endothelial dysfunction. Circulation. 2009;13:1266-86.
  5. Demirtunc R, Duman D, Basar M. The rela-tionship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complications. 2009;23(2):89-94.
  6. Lusher TF, Barton M. Biology of the endo-thelium. Clin Cardiol. 1997;10(11):3-10.
  7. Ametov AS. [Type 2 diabetes mellitus. Prob-lems and Solutions]. Moscow: GEOTAR-Media; 2012. 704 p. Russian.
  8. Mathewkutty S, McGuire DK. Platelet per-turbations in diabetes: implications for cardiovascu-lar disease risk and treatment. Expert Rev Cardiovasc Ther. 2009;7(5):541-9.
  9. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Rad Biol Med. 2003;34(12):1563-74.
  10. Heude B. Cognitive decline and fatty acid composition of erythrocyte membranes. Amer J Clin Nutrition. 2003;77(4):803-8.
  11. Vitkovskiy YuA, Kuznik BI, Solpov AV. [Pathogenetic significance of lymphocyte-platelet adhesion]. Medical immunology. 2006;5:745-52. Russian.
  12. Alekseev VV, Karpishchenko AI. [Medical laboratory technology. Manual of Clinical Laboratory Diagnostics]. Moscow: GEOTAR-Media; 2012. 472 p. Russian.
  13. Sawatzke CL, Solomons CC. Fixation and embedding of small volumes of platelets for trans-mission electron microscopy. J Clin Pathol. 1980;33(6):600-2.
  14. Mironov AA, Komissarchik YuYa, Mironov VA. Metodyi elektronnoy mikroskopii v biologii i meditsine: Metodicheskoe rukovodstvo. [Electron microscopy methods in biology and medicine : Methodological Guide]. St. Petersburg: Science; 1994. 400 p. Russian.
  15. Medvedev IV, Kumova TA. Oslablenie agregatsionnoy sposobnosti trombotsitov u bolnyih arterialnoy gipertoniey pri metabolicheskom sindrome na fone lozartana. [Weakening aggregability platelets in hypertensive patients with metabolic syndrome on a background of losartan]. Russ J Cardiol. 2008;5:53-5. Russian.
  16. Lakin GF. [Biometrics]. 4th ed rev and enl. Moscow: Vysshaya shkola; 1990. 352 p. Russian.

How to Cite

Pertseva, N. O. (2016). Relationship of morphological changes of blood cells with endothelial function, renal function and lipidemic profile in patients with type 2 diabetes mellitus with suboptimal glycemic control and hypertension. Морфологія / Morphologia / Morfologìâ, 10(1), 62–71. https://doi.org/10.26641/1997-9665.2016.1.62-71

Issue

Section

Статті